Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Can Assoc Gastroenterol. 2019 Dec;2(4):149-152. doi: 10.1093/jcag/gwy069. Epub 2019 Feb 1.

2.

Suppressive and Gut Reparative Functions of Human Type 1 T-regulatory Cells.

Cook L, Stahl M, Han X, Nazli A, MacDonald KN, Wong MQ, Tsai K, Dizzell S, Jacobson K, Bressler B, Kaushic C, Vallance BA, Steiner TS, Levings MK.

Gastroenterology. 2019 Sep 9. pii: S0016-5085(19)41310-3. doi: 10.1053/j.gastro.2019.09.002. [Epub ahead of print]

PMID:
31513797
3.

Use of Vedolizumab for the Treatment of Crohn's Disease.

Bressler B.

Gastroenterol Hepatol (N Y). 2019 Apr;15(4):204-206. No abstract available.

4.

Novel Microbial-Based Immunotherapy Approach for Crohn's Disease.

Sutcliffe S, Kalyan S, Pankovich J, Chen JMH, Gluck R, Thompson D, Bosiljcic M, Bazett M, Fedorak RN, Panaccione R, Axler J, Marshall JK, Mullins DW, Kabakchiev B, McGovern DPB, Jang J, Coldman A, Vandermeirsch G, Bressler B, Gunn H.

Front Med (Lausanne). 2019 Jul 19;6:170. doi: 10.3389/fmed.2019.00170. eCollection 2019.

5.

Rate of Corticosteroid-Induced Mood Changes in Patients with Inflammatory Bowel Disease: A Prospective Study.

Ou G, Bressler B, Galorport C, Lam E, Ko HH, Enns R, Telford J, Schaffer N, Lee T, Rosenfeld G.

J Can Assoc Gastroenterol. 2018 Sep;1(3):99-106. doi: 10.1093/jcag/gwy023. Epub 2018 Jun 4.

6.

Incidence of Suicide in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Zhang C, Byrne G, Lee T, Singer J, Giustini D, Bressler B.

J Can Assoc Gastroenterol. 2018 Sep;1(3):107-114. doi: 10.1093/jcag/gwy025. Epub 2018 Jul 11.

7.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.

J Can Assoc Gastroenterol. 2019 Aug;2(3):e1-e34. doi: 10.1093/jcag/gwz019. Epub 2018 Jul 10.

8.

Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF Exposure.

Bressler B, Williamson M, Sattin B, Camacho F, Steinhart AH.

J Can Assoc Gastroenterol. 2018 Sep;1(3):129-134. doi: 10.1093/jcag/gwy019. Epub 2018 May 10.

9.

Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates.

Moore AC, Bressler B.

Dig Dis Sci. 2019 May 15. doi: 10.1007/s10620-019-05668-6. [Epub ahead of print]

PMID:
31093812
10.

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases.

Papamichael K, Cheifetz AS, Melmed GY, Irving PM, Vande Casteele N, Kozuch PL, Raffals LE, Baidoo L, Bressler B, Devlin SM, Jones J, Kaplan GG, Sparrow MP, Velayos FS, Ullman T, Siegel CA.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1655-1668.e3. doi: 10.1016/j.cgh.2019.03.037. Epub 2019 Mar 27.

11.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1680-1713. doi: 10.1016/j.cgh.2019.02.043. Epub 2019 Mar 7.

PMID:
30853616
12.

Innate Control of Tissue-Reparative Human Regulatory T Cells.

Lam AJ, MacDonald KN, Pesenacker AM, Juvet SC, Morishita KA, Bressler B; iGenoMed Consortium, Pan JG, Sidhu SS, Rioux JD, Levings MK.

J Immunol. 2019 Apr 15;202(8):2195-2209. doi: 10.4049/jimmunol.1801330. Epub 2019 Mar 8.

PMID:
30850479
13.

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Rheumatol. 2019 Jul;46(7):751-754. doi: 10.3899/jrheum.180784. Epub 2019 Feb 1.

14.

Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease.

Ghosh S, Bressler B, Petkau J, Thakkar RB, Wang S, Skup M, Chao J, Panaccione R, Schreiber S.

Dig Dis Sci. 2019 May;64(5):1142-1149. doi: 10.1007/s10620-018-5419-3. Epub 2019 Jan 19.

PMID:
30659472
15.

IBDoc Canadian User Performance Evaluation.

Moore AC, Huang VW, Bourdages R, Fedorak RN, Reinhard C, Leung Y, Bressler B, Rosenfeld G.

Inflamm Bowel Dis. 2019 May 4;25(6):1107-1114. doi: 10.1093/ibd/izy357.

PMID:
30535387
16.

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Cutan Med Surg. 2019 Jan/Feb;23(1):50-74. doi: 10.1177/1203475418811335. Epub 2018 Nov 21.

17.

Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis.

Sham HP, Bazett M, Bosiljcic M, Yang H, Luk B, Law HT, Morampudi V, Yu HB, Pankovich J, Sutcliffe S, Bressler B, Marshall JK, Fedorak RN, Chen J, Jones M, Gunn H, Kalyan S, Vallance BA.

Front Immunol. 2018 Sep 27;9:2211. doi: 10.3389/fimmu.2018.02211. eCollection 2018.

18.

Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1.

Reinisch W, Bressler B, Curtis R, Parikh A, Yang H, Rosario M, Røseth A, Danese S, Feagan B, Sands BE, Ginsburg P, Dassopoulos T, Lewis J, Xu J, Wyant T.

Inflamm Bowel Dis. 2019 Mar 14;25(4):803-810. doi: 10.1093/ibd/izy304.

19.

Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives.

Bitton A, Vutcovici M, Lytvyak E, Kachan N, Bressler B, Jones J, Lakatos PL, Sewitch M, El-Matary W, Melmed G, Nguyen G; QI consensus group; Promoting Access and Care through Centers of Excellence-PACE program).

Inflamm Bowel Dis. 2019 Jan 10;25(2):403-409. doi: 10.1093/ibd/izy259.

PMID:
30169582
20.

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.

Steinhart AH, Panaccione R, Targownik L, Bressler B, Khanna R, Marshall JK, Afif W, Bernstein CN, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C.

Inflamm Bowel Dis. 2019 Jan 1;25(1):1-13. doi: 10.1093/ibd/izy247.

PMID:
30099529
21.

Appropriateness of Combination Therapy for Patients With Inflammatory Bowel Diseases: One Size Still Does Not Fit All.

Melmed GY, Kaplan GG, Sparrow MP, Velayos FS, Baidoo L, Bressler B, Cheifetz AS, Devlin SM, Irving PM, Jones J, Kozuch PL, Raffals LE, Siegel CA.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1829-1831. doi: 10.1016/j.cgh.2018.02.036. Epub 2018 Mar 2.

PMID:
29505910
22.

Prospective Comparison of Standard- Versus Low-Radiation-Dose CT Enterography for the Quantitative Assessment of Crohn Disease.

Rosenfeld G, Brown J, Vos PM, Leipsic J, Enns R, Bressler B.

AJR Am J Roentgenol. 2018 Feb;210(2):W54-W62. doi: 10.2214/AJR.17.18296. Epub 2017 Dec 20.

PMID:
29261354
23.

Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease.

Byrne G, Rosenfeld G, Leung Y, Qian H, Raudzus J, Nunez C, Bressler B.

Can J Gastroenterol Hepatol. 2017;2017:6496727. doi: 10.1155/2017/6496727. Epub 2017 Oct 18.

24.

Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease.

Allaire JM, Morampudi V, Crowley SM, Stahl M, Yu H, Bhullar K, Knodler LA, Bressler B, Jacobson K, Vallance BA.

Am J Physiol Gastrointest Liver Physiol. 2018 Mar 1;314(3):G360-G377. doi: 10.1152/ajpgi.00181.2017. Epub 2017 Nov 9. Review.

25.

Ustekinumab use in Crohn's disease: a Canadian tertiary care centre experience.

Greenup AJ, Rosenfeld G, Bressler B.

Scand J Gastroenterol. 2017 Dec;52(12):1354-1359. doi: 10.1080/00365521.2017.1373847. Epub 2017 Sep 8.

PMID:
28885058
26.

Transition clinic attendance is associated with improved beliefs and attitudes toward medicine in patients with inflammatory bowel disease.

Fu N, Jacobson K, Round A, Evans K, Qian H, Bressler B.

World J Gastroenterol. 2017 Aug 7;23(29):5405-5411. doi: 10.3748/wjg.v23.i29.5405.

27.

Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.

Nguyen GC, Boland K, Afif W, Bressler B, Jones JL, Weizman AV, Fowler S, Halder S, Huang VW, Kaplan GG, Khanna R, Murthy SK, Ruel J, Seow CH, Targownik LE, Chawla T, Guimaraes L, Fernandes A, Saleh S, Melmed GY.

Inflamm Bowel Dis. 2017 Jun;23(6):858-865. doi: 10.1097/MIB.0000000000001152.

PMID:
28509817
28.

Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.

Nguyen GC, Murthy SK, Bressler B, Lam MCW, Alali A, Toumi A, Reinglas J, Rampersad A, Weizman AV, Afif W; CINERGI group.

Inflamm Bowel Dis. 2017 May;23(5):695-701. doi: 10.1097/MIB.0000000000001068.

PMID:
28426451
29.

Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents.

Tse Y, Armstrong D, Andrews CN, Bitton A, Bressler B, Marshall J, Liu LW.

Can J Gastroenterol Hepatol. 2017;2017:8612189. doi: 10.1155/2017/8612189. Epub 2017 Feb 8.

30.

The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience.

Mitchell RA, Shuster C, Shahidi N, Galorport C, DeMarco ML, Rosenfeld G, Enns RA, Bressler B.

Can J Gastroenterol Hepatol. 2016;2016:5203898. Epub 2016 Nov 10.

31.

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.

Rosenfeld G, Greenup AJ, Round A, Takach O, Halparin L, Saadeddin A, Ho JK, Lee T, Enns R, Bressler B.

World J Gastroenterol. 2016 Sep 28;22(36):8211-8. doi: 10.3748/wjg.v22.i36.8211.

32.

Upper gastrointestinal bleeding following transcatheter aortic valve replacement: A retrospective analysis.

Stanger DE, Abdulla AH, Wong FT, Alipour S, Bressler BL, Wood DA, Webb JG.

Catheter Cardiovasc Interv. 2017 Aug 1;90(2):E53-E61. doi: 10.1002/ccd.26650. Epub 2016 Jul 9.

PMID:
27392808
33.

Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results.

Melmed GY, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Bressler B, Cheifetz AS, Devlin SM, Raffals LE, Vande Casteele N, Mould DR, Colombel JF, Dubinsky M, Sandborn WJ, Siegel CA.

Clin Gastroenterol Hepatol. 2016 Sep;14(9):1302-9. doi: 10.1016/j.cgh.2016.05.010. Epub 2016 May 14.

PMID:
27189916
34.

The role of vedolizumab in patients with moderate-to-severe Crohn's disease and ulcerative colitis.

Shahidi N, Bressler B, Panaccione R.

Therap Adv Gastroenterol. 2016 May;9(3):330-8. doi: 10.1177/1756283X16635081. Epub 2016 Mar 7. Review.

35.

Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: "Which One Is the Best for What?".

Greenup AJ, Bressler B, Rosenfeld G.

Inflamm Bowel Dis. 2016 May;22(5):1246-61. doi: 10.1097/MIB.0000000000000727. Review.

PMID:
27070909
36.

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.

Devlin SM, Melmed GY, Irving PM, Rubin DT, Kornbluth A, Kozuch PL, Raffals LE, Velayos FS, Sparrow MP, Baidoo L, Bressler B, Cheifetz AS, Jones J, Kaplan GG, Siegel CA.

Inflamm Bowel Dis. 2016 Jun;22(6):1418-24. doi: 10.1097/MIB.0000000000000764.

PMID:
27057680
37.

The Crohn's Disease-Ulcerative Colitis Clinical Appraisal.

D'Haens G, Bressler B, Danese S, Gibson P, Hanauer SB, Sandborn W.

Clin Gastroenterol Hepatol. 2016 Apr;14(4):638-9. doi: 10.1016/j.cgh.2016.01.017. Epub 2016 Feb 2. No abstract available.

38.

Evaluating if colonoscopies are essential after a diverticulitis diagnosis - Author response.

Ou G, Rosenfeld G, Bressler B.

Can J Surg. 2016 Feb;59(1):E1-2. No abstract available.

39.

Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype.

Carroll MW, Hamilton Z, Gill H, Simkin J, Smyth M, Espinosa V, Bressler B, Jacobson K.

Inflamm Bowel Dis. 2016 Feb;22(2):387-96. doi: 10.1097/MIB.0000000000000651.

PMID:
26752467
40.

Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study.

Sandborn WJ, Colombel JF, Ghosh S, Sands BE, Dryden G, Hébuterne X, Leong RW, Bressler B, Ullman T, Lakatos PL, Reinisch W, Xu LA, Luo A.

J Crohns Colitis. 2016 Apr;10(4):418-28. doi: 10.1093/ecco-jcc/jjv224. Epub 2015 Dec 30.

41.

Etrolizumab for induction of remission in ulcerative colitis.

Rosenfeld G, Parker CE, MacDonald JK, Bressler B.

Cochrane Database Syst Rev. 2015 Dec 2;(12):CD011661. doi: 10.1002/14651858.CD011661.pub2. Review.

PMID:
26630451
42.

Vedolizumab for the treatment of ulcerative colitis.

Shahidi N, Bressler B, Panaccione R.

Expert Opin Biol Ther. 2016;16(1):129-35. doi: 10.1517/14712598.2016.1121231. Epub 2015 Dec 9. Review.

PMID:
26567768
43.

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.

Khanna R, Bressler B, Levesque BG, Zou G, Stitt LW, Greenberg GR, Panaccione R, Bitton A, Paré P, Vermeire S, D'Haens G, MacIntosh D, Sandborn WJ, Donner A, Vandervoort MK, Morris JC, Feagan BG; REACT Study Investigators.

Lancet. 2015 Nov 7;386(10006):1825-34. doi: 10.1016/S0140-6736(15)00068-9. Epub 2015 Sep 3.

PMID:
26342731
44.

Tacrolimus Therapy for Ulcerative Colitis-Associated Post-Colectomy Enteritis.

Rush B, Berger L, Rosenfeld G, Bressler B.

ACG Case Rep J. 2014 Oct 10;2(1):33-5. doi: 10.14309/crj.2014.76. eCollection 2014 Oct.

45.

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials.

Jones JL, Kaplan GG, Peyrin-Biroulet L, Baidoo L, Devlin S, Melmed GY, Tanyingoh D, Raffals L, Irving P, Kozuch P, Sparrow M, Velayos F, Bressler B, Cheifetz A, Colombel JF, Siegel CA.

Clin Gastroenterol Hepatol. 2015 Dec;13(13):2233-40.e1-2; quiz e177-8. doi: 10.1016/j.cgh.2015.06.034. Epub 2015 Jun 30. Review.

PMID:
26142167
46.

Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease.

Bressler B, Panaccione R, Fedorak RN, Seidman EG.

Can J Gastroenterol Hepatol. 2015 Oct;29(7):369-72. Epub 2015 Jun 30. Review.

47.

Site-Specific Immunomodulator: A Novel Treatment for Crohn's Disease.

Bressler B, Bethel KP, Kleef R, Reynolds SL, Sutcliffe S, Mullins DW, Gunn H.

Gastroenterol Res Pract. 2015;2015:231243. doi: 10.1155/2015/231243. Epub 2015 May 12.

48.

Colonoscopy after CT-diagnosed acute diverticulitis: Is it really necessary?

Ou G, Rosenfeld G, Brown J, Chan N, Hong T, Lim H, Bressler B.

Can J Surg. 2015 Aug;58(4):226-31.

49.

ACP journal club. In ulcerative colitis, current use of thiopurines was associated with nonmelanoma skin cancer.

Bressler B.

Ann Intern Med. 2015 Mar 17;162(6):JC12. doi: 10.7326/ACPJC-2015-162-6-012. No abstract available.

PMID:
25775343
50.

Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.

Bressler B, Marshall JK, Bernstein CN, Bitton A, Jones J, Leontiadis GI, Panaccione R, Steinhart AH, Tse F, Feagan B; Toronto Ulcerative Colitis Consensus Group.

Gastroenterology. 2015 May;148(5):1035-1058.e3. doi: 10.1053/j.gastro.2015.03.001. Epub 2015 Mar 4. Review.

PMID:
25747596

Supplemental Content

Loading ...
Support Center